December 4, 2023

IGC Pharma, Inc. IGC has been granted European Patent No. 3193862 by the European Patent Workplace for its revolutionary “Cannabinoid Composition and Methodology for Treating Ache.”

The newly granted patent introduces a pioneering methodology for treating ache in people.

How It Works

Using a cream base infused with a singular mix of cannabinoids, together with tetrahydrocannabinol (THC) and cannabidiol (CBD) in addition to different compounds, the cream or gel is designed for transdermal absorption.

It interacts harmoniously with the peripheral nervous and immune techniques, successfully relieving ache with out psychotropic or antagonistic unwanted effects.

Current client traits point out a profound demand for secure and efficient ache aid, and IGC Pharma is searching for to advance ache aid therapies, stated Ram Mukunda, the corporate’s CEO.

“We aspire to redefine the usual for ache administration, offering more healthy alternate options to conventional drugs,” Makunda continued.

Learn additionally: Hashish Efficient For Continual Ache, Substituting Opioids: Johns Hopkins & Univ. Of Michigan Examine Confirms

Different Answer For Ache Administration

In America alone, over 56 million people grapple with debilitating arthritis, whereas 10 to 30% of complete joint arthroplasty sufferers endure persistent ache. Well being economists estimated the annual price of ache administration within the U.S. ranged from $560 billion to $635 billion in 2012, the corporate stated, citing the Journal of Ache’s information.

“Our portfolio now boasts a formidable 35 patent filings in numerous nations, together with the U.S. and Canada,” Makunda stated. “I imagine that our revolutionary strategy to ache aid has the potential to disrupt the trade, offering traders with a singular probability to be a part of a transformative journey. With a considerable addressable market and a robust mental property portfolio, we’re well-positioned for progress.”

Now learn: After 17 Years Of Aspect Results From Customary Medication, Continual Ache Affected person Finds Aid With Hashish: Examine

Missed the primary wave of hashish investments? Don’t make that mistake once more.

Specialists imagine hashish shares have discovered their ground and at the moment are poised for unprecedented progress. Be part of Benzinga PotProfits. Profit from Michael Berger’s sharp evaluation, revealing high hashish inventory alternatives and well timed updates. Expertise the potential of 10%+ returns in simply 90 days. Our 4.5-star Marketfy ranking speaks volumes. Safe your place on this booming sector with a 30-day money-back assure. The time to speculate is now, earlier than everybody else realizes it. Safe your income with Benzinga. Click on right here now to study extra.

IGC Value Motion

IGC’s shares traded 6.66% decrease at $0.3001 per share throughout the pre-market session on Friday morning

Picture: Courtesy of Towfiqu barbhuiya on Unsplash

Supply Hyperlink :